A gift to the 70th anniversary of the founding of the People's Republic of China ③ Seeking to upgrade Hefei High-tech Zone "Jianghuai Peptide Valley" is gradually becoming immature

Date：

2019-11-21

Editor's Note: In recent years, Hefei High-tech Industrial Development Zone (hereinafter referred to as Hefei High-tech Zone) has increased policy support and promoted the concentration of industrial elements. It has been approved as the Central Center of National Health and Medical Big Data, and the Provincial Biomedicine and High-end Medical Equipment Cluster Development Base , the city's health care town, and the overall scale of the biomedical industry has maintained a steady growth. In 2018, there were more than 200 enterprises in the life and health industry in Hefei High-tech Zone, and the industrial scale reached more than 16.7 billion yuan, with a growth rate of more than 20%. Precision medicine and health big data ranked among the forefront of the national industry. The life and health industry is becoming a new engine for the development of modern economy in Hefei High-tech Zone.

Seeking to upgrade the "Jianghuai Peptide Valley" in Hefei High-tech Zone is gradually becoming immature

On the afternoon of August 30, the biomedical industry in Hefei High-tech Zone concentrated on interviewing media reporters, and was attracted by the mice in the laboratory of Anhui Huibang Bioengineering Co., Ltd. (referred to as Huibang Biology). According to Wang Zhongliang, chairman of Huibang Biotechnology, this is the source of biomedical preparations and the core of the biomedical industry. There are more than 200 biomedical companies like Huibang Biotechnology in Hefei High-tech Zone. It is one of the strategic industries that this industrial park seeks to upgrade, and it is also the basis for building the "Jianghuai Peptide Valley" biomedical industry cluster.

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.